<p>Dr Tiene Bauters discusses how the interpretation of interchangeability and rules around switching of biosimilars differ between healthcare systems across the globe and the resulting implications on access to care.</p>

Dr Tiene Bauters discusses how the interpretation of interchangeability and rules around switching of biosimilars differ between healthcare systems across the globe and the resulting implications on access to care.

Switching and interchangeability: what you need to know

Be engaged by the experts through the Hospital Pharmacy Europe podcast series. Editor Andrea Porter and the editorial team speak with pharmacy specialists about key areas of clinical practice and hear how innovative developments are affecting patients within secondary healthcare.

Share Switching and interchangeability: what you need to know

Sign up to save your podcasts

Switching and interchangeability: what you need to know

Switching and interchangeability: what you need to know